| Literature DB >> 27688877 |
Nataliya G Batina1, Christopher J Crnich2, David F Anderson3, Dörte Döpfer4.
Abstract
BACKGROUND: Residents of nursing homes are commonly colonized with methicillin-resistant Staphylococcus aureus (MRSA) but there is a limited understanding of the dynamics and determinants of spread in this setting. To address this gap, we sought to use mathematical modeling to assess the epidemic potential of MRSA in nursing homes and to determine conditions under which non-USA300 and USA300 MRSA could be eliminated or reduced in the facilities.Entities:
Keywords: Colonization; Conditions for MRSA reduction; Epidemic potential; Non-USA300 MRSA; Nursing homes; USA300 MRSA
Year: 2016 PMID: 27688877 PMCID: PMC5034495 DOI: 10.1186/s13756-016-0130-7
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Fig. 1Model diagrams. Compartmental models which describe transmission dynamics of MRSA in nursing homes. The rectangles represent cohorts of residents; the arrows represent inflow to and outflow from each compartment due to disease transmission, clearance, admission or discharge, including death. a Co-colonization model (model parameters are described in Table 1), S is the cohort of residents susceptible to any MRSA; I is the cohort of residents colonized with non-USA300 and susceptible to USA300; I is the cohort of residents colonized with USA300 and susceptible to non-USA300; I is the cohort of residents colonized with both MRSA strains; b Model for colonization with a single MRSA strain-type, either non-USA300 or USA300 MRSA, where λ*, γI*, b , g , and I* represent the corresponding parameters specific to each single strain model, non-USA300 or USA300
Parameters and initial occupancy for the co-colonization model
| Description | Symbol | Value (95 % CI) | Estimated or Observed |
|---|---|---|---|
| Initial occupancy in each compartment | |||
| Number of residents susceptible to any MRSA |
| 350 | observed |
| Number of residents colonized with non-USA300 |
| 79 | observed |
| Number of residents colonized with USA300 |
| 14 | observed |
| Number of residents co-colonized with non-USA300 and USA300 |
| 3 | observed |
| Total number of residents |
| 446 | observed |
| Model Parameters | |||
| Probability of admission of MRSA-colonized residents |
| 0.215 | estimated |
| Discharge rate of susceptibles (per 3 months) |
| 0.101 | estimated |
| Discharge rate of MRSA-colonized (per 3 months) |
| 0.074 | estimated |
| Proportion of residents colonized with non-USA300 at baseline |
| 0.823 | observed |
| Proportion of residents colonized with USA300 at baseline |
| 0.146 | observed |
| Proportion of residents co-colonized with both strains at baseline |
| 0.031 | observed |
| Acquisition rate for non-USA300a |
| ||
| - generalb | 0.029 (0.022, 0.038) | estimated | |
| - w/o ABc | 0.020 (0.014, 0.030) | estimated | |
| - with ABd | 0.042 (0.030, 0.061) | estimated | |
| Acquisition rate for USA300a |
| ||
| - generalb | 0.006 (0.004, 0.011) | estimated | |
| - w/o ABc | 0.004 (0.002, 0.010) | estimated | |
| - with ABd | 0.009 (0.005, 0.019) | estimated | |
| Clearance rate for non-USA300a |
| ||
| - generalb | 0.116 (0.088, 0.152) | estimated | |
| - w/o ABc | 0.125 (0.086, 0.179) | estimated | |
| - with ABd | 0.107 (0.074, 0.163) | estimated | |
| Clearance rate for USA300a |
| ||
| - generalb | 0.137 (0.082, 0.228) | estimated | |
| - w/o ABc | 0.155 (0.079, 0.328) | estimated | |
| - with ABd | 0.125 (0.064, 0.266) | estimated | |
AB, antibiotic use in the past 3 months
aRelative frequency per 3 months
bThe rate irrespective of antibiotic use in the past 3 months
cThe rate corresponding to No level of antibiotic use in the past 3 months
dThe rate corresponding to Yes level of antibiotic use in the past 3 months
Fig. 2Distribution of subjects colonized with strain-specific MRSA over time under selected scenarios derived from the deterministic model. The curve Observed represents the percent of colonized subjects over time based on the observed data; Scenario 1 shows the percent of colonized subjects under the assumption of no intra-facility cross-transmission; Scenario 2 reflects the percent of colonized subjects when MRSA clearance rates are increased two-fold; Scenario 3 represents the percent of colonized over time when all positive MRSA admissions are eliminated; Scenario 4 shows the percent of colonized over time when a half of all positive MRSA admissions are eliminated. a Percent colonized with non-USA300; b Percent colonized with USA300; c Percent co-colonized with non-USA300 and USA300
Fig. 3Sensitivity of the point prevalence of MRSA to the estimated parameters. The solid black lines represent the strain-specific point prevalence of MRSA given the estimated model parameter (Table 1). The grey lines represent the point prevalence of MRSA calculated for various values of the parameter; these values are displayed as labels above or below the lines. a Sensitivity of the prevalence of non-USA300 to MRSA admission prevalence, λ; b Sensitivity of the prevalence of USA300 to MRSA admission prevalence, λ; c Sensitivity of the prevalence of non-USA300 to discharge rates of non-colonized, γS; d Sensitivity of the prevalence of USA300 to discharge rates of non-colonized, γS; e Sensitivity of the prevalence of non-USA300 to discharge rates of colonized, γI; f Sensitivity of the prevalence of USA300 to discharge rates of colonized, γI; g Sensitivity of the prevalence of non-USA300 to acquisition rates of non-USA300, b ; h Sensitivity of the prevalence of USA300 to acquisition rates of USA300, b ; i Sensitivity of the prevalence of non-USA300 to clearance rates of non-USA300, g ; j Sensitivity of the prevalence of USA300 to clearance rates of USA300, g
Basic reproduction number for strain-independent and strain-specific MRSA
| Basic Reproduction Number | Point Estimate (95 % CI) | ||
|---|---|---|---|
| General (irrespective of AB) | w/o AB | with AB | |
| Strain-independent MRSA, R0 | 0.18 (0.13, 0.23) | 0.12 (0.07, 0.17) | 0.28 (0.16, 0.40) |
| Non-USA300, R01 | 0.16 (0.11, 0.21) | 0.11 (0.06, 0.15) | 0.24 (0.15, 0.34) |
| USA300, R03 | 0.04 (0.01, 0.06) | 0.02 (0.00, 0.05) | 0.05 (0.02, 0.09) |
AB, antibiotic use in the past 3 months
Fig. 4Sensitivity of the basic reproduction number, R0, to changes in acquisition and clearance rates, one at a time. The horizontal dotted lines highlight the R0 threshold value of 1. The stars display the actual value of R0, that is, the value calculated using model parameters (Table 1). a Sensitivity of R0 to acquisition rates of non-USA300 (b ) and USA300 (b ); b Sensitivity of R0 to clearance rates of non-USA300 (g ) and USA300 (g )
Fig. 5Impact of antibiotic use in the past 3 months on MRSA point prevalence and epidemic potential. Black lines represent the point prevalence of colonized who used antibiotics in the past 3 months, and grey lines show the point prevalence of those who did not. Solid lines denote the distribution of colonized when MRSA acquisition and clearance rates were set at the respective point estimates (Table 1). Dashed lines represent the distribution of colonized in hypothetical scenarios which employed the combinations of upper and lower bounds of the 95 % CI’s of the respective acquisition and clearance rates. Thus, the dashed lines above the corresponding solid lines represent scenarios with high acquisition rates and low clearance rates, while dashed lines below the corresponding solid lines show scenarios with low acquisition and high clearance rates. a Distribution of colonized with non-USA300; b Distribution of colonized with USA300; c Distribution of co-colonized with non-USA300 and USA300
Transitions between the states of the stochastic model
| Event | Transition | Rate Constant | Rate |
|---|---|---|---|
| Admission of susceptible residents | ∅ → | (1 − | (1 − |
| Discharge of susceptible residents |
|
|
|
| Admission of colonized with non-USA300 | ∅ → | ( | ( |
| Discharge of colonized with non-USA300 |
|
| ( |
| Transmission of non-USA300 from colonized with non-USA300 to susceptible |
|
|
|
| Transmission of non-USA300 from co-colonized to susceptible |
|
|
|
| Clearance of colonized with non-USA300 |
|
|
|
| Admission of colonized with USA300 | ∅ → | ( | ( |
| Discharge of colonized with USA300 |
|
| ( |
| Transmission of USA300 from colonized with USA300 to susceptible |
|
|
|
| Transmission of USA300 from co-colonized to susceptible |
|
|
|
| Clearance of colonized with USA300 |
|
|
|
| Admission of co-colonized with both strains | ∅ → | ( | ( |
| Discharge of co-colonized with both strains |
|
| ( |
| Transmission of USA300 from co-colonized to colonized with non-USA300 |
|
|
|
| Transmission of USA300 from colonized with USA300 to colonized with non-USA300 |
|
|
|
| Transmission of non-USA300 from co-colonized to colonized with USA300 |
|
|
|
| Transmission of non-USA300 from colonized with non-USA300 to colonized with USA300 |
|
|
|
| Clearance of co-colonized from USA300 |
|
|
|
| Clearance of co-colonized from non-USA300 |
|
|
|